EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
3.250
+0.020 (0.62%)
At close: Oct 2, 2026, 4:00 PM EDT
3.260
+0.010 (0.31%)
After-hours: Oct 2, 2026, 7:44 PM EDT
EyePoint Market Cap
EyePoint has a market cap or net worth of $280.19 million as of October 2, 2026. Its market cap has decreased by -68.53% in one year.
Market Cap
280.19M
Enterprise Value
122.08M
1-Year Change
-68.53%
Ranking
Category
Stock Price
$3.25
ChartMarket Cap Chart
Since January 27, 2005, EyePoint's market cap has decreased from $388.60M to $280.19M, a decrease of -27.90%. That is a compound annual growth rate of -1.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 280.19M | -81.48% |
| Dec 31, 2025 | 1.51B | 197.44% |
| Dec 31, 2024 | 508.50M | -37.68% |
| Dec 29, 2023 | 816.00M | 583.99% |
| Dec 30, 2022 | 119.30M | -66.13% |
| Dec 31, 2021 | 352.20M | 273.09% |
| Dec 31, 2020 | 94.40M | -43.68% |
| Dec 31, 2019 | 167.60M | -6.53% |
| Dec 31, 2018 | 179.30M | 266.67% |
| Dec 29, 2017 | 48.90M | -16.27% |
| Dec 30, 2016 | 58.40M | -58.82% |
| Dec 31, 2015 | 141.80M | 17.58% |
| Dec 31, 2014 | 120.60M | 12.71% |
| Dec 31, 2013 | 107.00M | 279.43% |
| Dec 31, 2012 | 28.20M | 22.08% |
| Dec 30, 2011 | 23.10M | -75.61% |
| Dec 31, 2010 | 94.70M | 44.14% |
| Dec 31, 2009 | 65.70M | 281.98% |
| Dec 31, 2008 | 17.20M | -70.19% |
| Dec 31, 2007 | 57.70M | -25.93% |
| Dec 29, 2006 | 77.90M | -62.73% |
| Dec 30, 2005 | 209.00M | -46.22% |
| Jan 27, 2005 | 388.60M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vanda Pharmaceuticals | 304.13M |
| Evommune | 303.04M |
| Century Therapeutics | 298.77M |
| Abeona Therapeutics | 295.07M |
| Clinuvel Pharmaceuticals | 294.75M |
| SAB Biotherapeutics | 292.98M |
| X4 Pharmaceuticals | 287.53M |
| Fate Therapeutics | 285.17M |